Physician Assistant in Unalaska, AK Accepting Medicare
4 Physician Assistant nurses found. Showing 1 - 4
 Mrs. Morwenna Theresa Unger, PAC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 34 Lavelle Ct., Iliuliuk Family & Health Services, Inc (box 144), Unalaska, AK 99685 Phone: 907-581-1202 |
 Christopher Stramecky, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 34 Lavelle Court, Unalaska, AK 99685 Phone: 907-359-3445 |
Ms. Wendy Eileen Hladick, PA Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: Iliuliuk Family And Health Services, Lavelle Court, Unalaska, AK 99685 Phone: 907-581-6563 |
Maria Green Kallman, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 34 Lavelle Ct., Unalaska, AK 99685 Phone: 907-581-1202 |
News Archive
Cancer can be changed from terminal to chronic by cutting liver piece by piece
New surgical methods give hope to patients with cancer that has spread from the intestine to the liver. The disease can be changed from terminal to chronic by cutting the liver piece by piece using keyhole surgery.
Medicare 'doc fix' on Congress' to-do list
News outlets report on Congress' pivotal week ahead, which could include an extension of the payroll tax break and a patch to prevent a scheduled cut in Medicare physician payments.
FDA approves CSL Behring's Hizentra for PI
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for HizentraTM, Immune Globulin Subcutaneous (Human), 20% Liquid, for treating patients diagnosed with primary immunodeficiency (PI). A once weekly immunoglobulin (Ig) replacement therapy, Hizentra provides effective protection against infection by maintaining a steady and normal level of immunoglobulin in the body.
Study describes new pharmacological resistance to colon cancer
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.
› Verified 7 days ago